[LGND] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
24-Feb-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -4.89%
YoY- 75.82%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 14,973 10,608 15,958 14,737 13,005 9,580 11,651 18.18%
PBT 901 1,241 2,150 2,008 2,025 3,804 1,370 -24.35%
Tax 124 -47 53 139 60 110 66 52.20%
NP 1,280 1,592 2,097 1,869 1,965 6,091 1,495 -9.82%
Tax Rate -13.76% 3.79% -2.47% -6.92% -2.96% -2.89% -4.82% -
Total Cost 13,693 9,016 13,861 12,868 11,040 3,489 10,156 22.02%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin 8.55 15.01 13.14 12.68 15.11 63.58 12.83 -23.68%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS 0.06 0.08 0.10 0.09 0.10 0.30 0.07 -9.75%
EPS Diluted 0.06 0.07 0.10 0.09 0.09 0.30 0.07 -9.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.